Mahdi Ramezani

Dr. Mahdi Ramezani

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 October 2020 in Journal of Chemical Neuroanatomy
Verified
Journal Article
Closed access
Mahdi RamezaniMahdi Ramezani
Mahdi Ramezani
AKAlireza Komaki
Alireza Komaki
NHNasrin Hashemi-Firouzi
Nasrin Hashemi-Firouzi
KMKeywan Mortezaee
Keywan Mortezaee
NFNafiseh Faraji
Nafiseh Faraji
ZGZoleikha Golipoor
Zoleikha Golipoor


14 June 2020 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
FMFarhad Monsef
Farhad Monsef
TATayebe Artimani
Tayebe Artimani
ZAZohreh Alizadeh
Zohreh Alizadeh
Mahdi RamezaniMahdi Ramezani
Mahdi Ramezani
GSGhasem Solgi
Ghasem Solgi
SASara Sara Soleimani Asl
Sara Sara Soleimani Asl

28 June 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
PHParisa Habibi
Parisa Habibi
SSSiamak Shahidi
Siamak Shahidi
MKMaryam Khajvand-Abedini
Maryam Khajvand-Abedini
ZSZahra Shahabi
Zahra Shahabi
ناناصر احمدی اصل
ناصر احمدی اصل
AKAlireza Komaki
Alireza Komaki
Menopause may increase the risk of Alzheimer’s disease (AD) dementia. This study aimed to use young plasma therapy (YPT) to improve dementia caused by AD in aged ovariectomized rats. Female Wistar rats were used in the following groups: (a) young (CY) (180–200 g, 2–3 months, n = 10) and (b) old groups (250–350 g, 22–24 months, n = 60). The old rats were randomly assigned to six sub-groups: (1) control, (2) sham, (3) ovariectomized group (OVX), (4) OVX + Alzheimer disease (OVX + AD), (5) OVX + AD+ 17β-Estradiol (OVX + AD + E), and (6) OVX + AD + young plasma (OVX + AD + YP). Cognitive behaviors were evaluated using NOR, MWM, and PAL tests. MiR-134a, SIRT-1, CREB, and BDNF expressions were measured using real-time PCR and western blot, respectively. Oxidative stress in hippocampal tissue was assayed using ELISA kits. OVX and AD caused significant cognitive impairment (p < 0.001), up-regulated miR-134a (p < 0.001), down-regulated SIRT-1, CREB, and BDNF protein expression (p < 0.001), and decreased antioxidant marker levels (p < 0.001) compared to the sham group. YPT significantly restored miR-134a (p < 0.001), SIRT-1 (p < 0.001), CREB (p < 0.001), and BDNF (p < 0.001) protein expression in OVX + AD rats. YPT, as much as or more than estrogen therapy (ERT), significantly improved oxidative stress and down-regulated miR-134a expression and the up-regulation of SIRT-1, CREB, and BDNF proteins in OVX + AD rats (p < 0.001). YPT significantly improved histological alteration compared to the OVX + AD group (p < 0.001). As a non-pharmacological treatment, YPT can improve the expression of miR-134a and SIRT-1, CREB, and BDNF proteins as much as or more than estrogen therapy, ameliorating AD-induced dementia in aged OVX rats.

5 January 2018 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
PDF file
Mahdi RamezaniMahdi Ramezani
Mahdi Ramezani
MSMojdeh Salehnia
Mojdeh Salehnia
MJMina Jafarabadi
Mina Jafarabadi